Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement.

Importance An estimated 12% of adults 18 years or older and 8% of adolescents aged 12 to 17 years report unhealthy use of prescription or illegal drugs in the US. Objective To update its 2008 recommendation, the USPSTF commissioned reviews of the evidence on screening by asking questions about drug use and interventions for unhealthy drug use in adults and adolescents. Population This recommendation statement applies to adults 18 years or older, including pregnant and postpartum persons, and adolescents aged 12 to 17 years in primary care settings. This statement does not apply to adolescents or adults who have a currently diagnosed drug use disorder or are currently undergoing or have been referred for drug use treatment. This statement applies to settings and populations for which services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. Evidence Assessment In adults, the USPSTF concludes with moderate certainty that screening by asking questions about unhealthy drug use has moderate net benefit when services for accurate diagnosis of unhealthy drug use or drug use disorders, effective treatment, and appropriate care can be offered or referred. In adolescents, because of the lack of evidence, the USPSTF concludes that the benefits and harms of screening for unhealthy drug use are uncertain and that the balance of benefits and harms cannot be determined. Recommendation The USPSTF recommends screening by asking questions about unhealthy drug use in adults 18 years or older. Screening should be implemented when services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred. (Screening refers to asking questions about unhealthy drug use, not testing biological specimens.) (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for unhealthy drug use in adolescents. (I statement).

[1]  Carrie D. Patnode,et al.  Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2020, JAMA.

[2]  ACOG COMMITTEE OPINION , 2022 .

[3]  S. Blackwell Obstetric Care Consensus No. 8: Interpregnancy Care. , 2019, Obstetrics and gynecology.

[4]  Jacek Kopec,et al.  The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The lancet. Psychiatry.

[5]  Chyke A Doubeni,et al.  Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.

[6]  J. McKinney,et al.  ACOG Committee Opinion No. 736: Optimizing Postpartum Care. , 2018, Obstetrics and gynecology.

[7]  Lawrence Scholl,et al.  Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017 , 2018, MMWR. Morbidity and mortality weekly report.

[8]  S. Bewley,et al.  Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. , 2018, Obstetrics and gynecology.

[9]  J. Cook,et al.  Epidemiology and Effects of Substance Use in Pregnancy. , 2017, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[10]  J. Hagan,et al.  Bright Futures Guidelines for Health Supervision of Infants, Children, and Adolescents, 4th Ed , 2017 .

[11]  Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy. , 2017, Obstetrics and gynecology.

[12]  C. Hammond The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders. , 2016, Child and adolescent psychiatric clinics of North America.

[13]  Aditi Sharma,et al.  Neurobiology of Adolescent Substance Use Disorders. , 2016, Child and adolescent psychiatric clinics of North America.

[14]  S. Levy,et al.  Substance Use Screening, Brief Intervention, and Referral to Treatment , 2016, Pediatrics.

[15]  A. Siu Screening for Depression in Children and Adolescents: US Preventive Services Task Force Recommendation Statement , 2016, Pediatrics.

[16]  M. Phipps,et al.  Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[17]  A. Siu Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement. , 2015, Annals of internal medicine.

[18]  Dawn W. Foster,et al.  Substance Use in the Perinatal Period , 2015, Current Psychiatry Reports.

[19]  Committee Opinion No. 633: Alcohol Abuse and Other Substance Use Disorders Ethical Issues in Obstetric and Gynecologic Practice , 2015, Obstetrics and gynecology.

[20]  M. LeFevre Screening for suicide risk in adolescents, adults, and older adults in primary care: U.S. Preventive Services Task Force recommendation statement. , 2014, Annals of internal medicine.

[21]  V. Moyer Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: U.S. Preventive Services Task Force recommendation statement. , 2014, Annals of internal medicine.

[22]  Committee Opinion No. 598: The Initial Reproductive Health Visit , 2014 .

[23]  V. Moyer Primary Care Interventions to Prevent Tobacco Use in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement* , 2013, Pediatrics.

[24]  Alan D. Lopez,et al.  Measuring the global burden of disease. , 2013, The New England journal of medicine.

[25]  Jennifer A. Robinson,et al.  A Longitudinal Study of Risk Factors for Incident Drug Use in Adults: Findings from a Representative Sample of the US Population , 2011, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[26]  Committee Opinion No. 479: Methamphetamine abuse in women of reproductive age. , 2011, Obstetrics and gynecology.

[27]  AGOG Committee Opinion No. 473: substance abuse reporting and pregnancy: the role of the obstetrician-gynecologist. , 2011, Obstetrics and gynecology.